Hypothalamic and basal ganglia projections to the posterior thalamus: Possible role in modulation of migraine headache and photophobia

Neuroscience

Volumn 248, Issue , 2013, Pages 359-368

  Kagan, R ^a   Kainz, V ^b   Burstein, R ^b   Noseda, R ^b  

^a HARVARD COLLEGE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Food intake; Migraine triggers; Neurotransmitters; Premonitory symptoms; Sleep; Thalamus

Indexed keywords

ACETYLCHOLINE; CHOLECYSTOKININ; DOPAMINE; HISTAMINE; 2-HYDROXY-4,4'-DIAMIDINOSTILBENE, METHANESULFONATE SALT; FLUORESCENT DYE; STILBAMIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN MAPPING; BRAIN NERVE CELL; CONTROLLED STUDY; DIAGONAL BAND OF BROCA; DOPAMINERGIC NERVE CELL; EMOTION; FOREBRAIN; HYPOTHALAMUS; MALE; MEAL; MIGRAINE; NONHUMAN; PHOTOPHOBIA; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SLEEP; THALAMUS; TRIGEMINOVASCULAR NEURON; TUBEROMAMMILLARY NUCLEUS; ANIMAL; CHEMISTRY; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; NERVE CELL; NERVE TRACT; PAIN; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT;

ANIMALS; BASAL GANGLIA; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT DYES; HYPOTHALAMUS; MALE; MIGRAINE DISORDERS; NEURAL PATHWAYS; NEURONS; PAIN; PHOTOPHOBIA; RATS; RATS, SPRAGUE-DAWLEY; STILBAMIDINES; THALAMUS;

EID: 84880601876     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.06.014     Document Type: Article

References (40)

1. Aguggia M., Cavallini M., Divito N., Ferrero M., Lentini A., Montano V., Tinebra M.C., Saracco M.G., Valfre W. Sleep and primary headaches. Neurol Sci 2011, 32(Suppl. 1):S51-S54.
2. Akerman S., Holland P.R., Goadsby P.J. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci 2011, 12:570-584.
3. Bigal M.E., Bordini C.A., Speciali J.G. Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial. J Emerg Med 2002, 23:141-148.
4. Burstein R., Jakubowski M., Garcia-Nicas E., Kainz V., Bajwa Z., Hargreaves R., Becerra L., Borsook D. Thalamic sensitization transforms localized pain into widespread allodynia. Ann Neurol 2010, 68:81-91.
5. Cerbo R., Barbanti P., Buzzi M.G., Fabbrini G., Brusa L., Roberti C., Zanette E., Lenzi G.L. Dopamine hypersensitivity in migraine: role of the apomorphine test. Clin Neuropharmacol 1997, 20:36-41.
6. Charbit A.R., Akerman S., Goadsby P.J. Dopamine: what's new in migraine?. Curr Opin Neurol 2010, 23:275-281.
7. Colman I., Brown M.D., Innes G.D., Grafstein E., Roberts T.E., Rowe B.H. Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ 2004, 329:1369-1373.
8. Denuelle M., Fabre N., Payoux P., Chollet F., Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache 2007, 47:1418-1426.
9. Elmquist J.K., Elias C.F., Saper C.B. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 1999, 22:221-232.
10. Gao Q., Horvath T.L. Neurobiology of feeding and energy expenditure. Annu Rev Neurosci 2007, 30:367-398.
11. Giffin N.J., Ruggiero L., Lipton R.B., Silberstein S.D., Tvedskov J.F., Olesen J., Altman J., Goadsby P.J., Macrae A. Premonitory symptoms in migraine: an electronic diary study. Neurology 2003, 60:935-940.
12. Goadsby P.J., Charbit A.R., Andreou A.P., Akerman S., Holland P.R. Neurobiology of migraine. Neuroscience 2009, 161:327-341.
13. Gori S., Morelli N., Maestri M., Fabbrini M., Bonanni E., Murri L. Sleep quality, chronotypes and preferential timing of attacks in migraine without aura. J Headache Pain 2005, 6:258-260.
14. Gori S., Lucchesi C., Morelli N., Maestri M., Bonanni E., Murri L. Sleep-related migraine occurrence increases with aging. Acta Neurol Belg 2012, 112:183-187.
15. Haas H., Panula P. The role of histamine and the tuberomammillary nucleus in the nervous system. Nat Rev Neurosci 2003, 4:121-130.
16. Ikeda K., Kawase Y., Takazawa T., Iwamoto K., Ito H., Murata K., Sato R., Nagaoka T., Sekine T., Nagata R., Nakamura Y., Hirayama T., Ishikawa Y., Miura K., Yoshii Y., Iwasaki Y. Scopolamine-induced migraine like headache. Intern Med 2009, 48:681-685.
17. Kalinchuk A.V., Lu Y., Stenberg D., Rosenberg P.A., Porkka-Heiskanen T. Nitric oxide production in the basal forebrain is required for recovery sleep. J Neurochem 2006, 99:483-498.
18. Kang L., Routh V.H., Kuzhikandathil E.V., Gaspers L.D., Levin B.E. Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes 2004, 53:549-559.
19. Karnani M., Burdakov D. Multiple hypothalamic circuits sense and regulate glucose levels. Am J Physiol Regul Integr Comp Physiol 2011, 300:R47-55.
20. Kostin A., Stenberg D., Kalinchuk A.V., Porkka-Heiskanen T. Nitric oxide modulates the discharge rate of basal forebrain neurons. Psychopharmacology (Berl) 2008, 201:147-160.
21. Krabbe A.A., Olesen J. Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms. Pain 1980, 8:253-259.
22. Lassen L.H., Thomsen L.L., Olesen J. Histamine induces migraine via the H1-receptor. Support for the NO hypothesis of migraine. Neuroreport 1995, 6:1475-1479.
23. Lin J.S., Hou Y., Sakai K., Jouvet M. Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J Neurosci 1996, 16:1523-1537.
24. Malick A., Jakubowski M., Elmquist J.K., Saper C.B., Burstein R. A neurohistochemical blueprint for pain-induced loss of appetite. Proc Natl Acad Sci U S A 2001, 98:9930-9935.
25. Marmura M.J. Use of dopamine antagonists in treatment of migraine. Curr Treat Options Neurol 2012, 14:27-35.
26. Monti J.M., Jantos H. Microinjection of the nitric oxide synthase inhibitor L-NAME into the lateral basal forebrain alters the sleep/wake cycle of the rat. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:239-247.
27. Nicolodi M., Galeotti N., Ghelardini C., Bartolini A., Sicuteri F. Central cholinergic challenging of migraine by testing second-generation anticholinesterase drugs. Headache 2002, 42:596-602.
28. Noseda R, Burstein R (in press) Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain.
29. Noseda R., Kainz V., Jakubowski M., Gooley J.J., Saper C.B., Digre K., Burstein R. A neural mechanism for exacerbation of headache by light. Nat Neurosci 2010, 13:239-245.
30. Olesen J., Burstein R., Ashina M., Tfelt-Hansen P. Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 2009, 8:679-690.
31. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2008, Academic Press.
32. Peroutka S.J. Dopamine and migraine. Neurology 1997, 49:650-656.
33. Qu D., Ludwig D.S., Gammeltoft S., Piper M., Pelleymounter M.A., Cullen M.J., Mathes W.F., Przypek R., Kanarek R., Maratos-Flier E. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 1996, 380:243-247.
34. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
35. Schwartz J.C., Arrang J.M., Garbarg M., Pollard H., Ruat M. Histaminergic transmission in the mammalian brain. Physiol Rev 1991, 71:1-51.
36. Sicuteri F. Dopamine, the second putative protagonist in headache. Headache 1977, 17:129-131.
37. Steininger T.L., Alam M.N., Gong H., Szymusiak R., McGinty D. Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat. Brain Res 1999, 840:138-147.
38. Takahashi K., Lin J.S., Sakai K. Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. J Neurosci 2006, 26:10292-10298.
39. Tek D.S., McClellan D.S., Olshaker J.S., Allen C.L., Arthur D.C. A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med 1990, 19:1083-1087.
40. Zant J.C., Rozov S., Wigren H.K., Panula P., Porkka-Heiskanen T. Histamine release in the basal forebrain mediates cortical activation through cholinergic neurons. J Neurosci 2012, 32:13244-13254.